175 related articles for article (PubMed ID: 33729141)
1. [Application of quantitative electroencephalogram monitoring in evaluating thrombolytic effect of acute cerebral infarction].
Jin L; Wang Y; Lyu Z; Zhang C
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Feb; 33(2):207-210. PubMed ID: 33729141
[TBL] [Abstract][Full Text] [Related]
2. Effect of Standardized Perioperative Management on EEG Indexes and Nerve and Limb Functions of Patients with Acute Cerebral Infarction Undergoing Mechanical Thrombectomy.
Gong Y; Wang J
Dis Markers; 2022; 2022():1686891. PubMed ID: 36199820
[TBL] [Abstract][Full Text] [Related]
3. [Effect of prehospital intervention based on emergency medical services on door-to-needle time of thrombolysis in acute ischemic stroke].
Wang Y; Zhang C; Sun W; Hu X; Lyu Z; Liu W
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Jul; 30(7):667-670. PubMed ID: 30045795
[TBL] [Abstract][Full Text] [Related]
4. [Effect of intravenous thrombolysis with recombinant tissue type plasminogen activator (rt-PA) in different time windows on acute cerebral infarction patients with atrial fibrillation].
Guo Y; Zhang CH; Wang HY; Lin YN; Wang Y; Sun XP
Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(26):2054-8. PubMed ID: 27468616
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of influencing factors of neurological function recovery and cerebral hemorrhage transformation after intravenous thrombolysis in patients with acute ischemic stroke].
Chen Y; Zhang Q; You N; Wang L
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Nov; 32(11):1340-1345. PubMed ID: 33463494
[TBL] [Abstract][Full Text] [Related]
6. Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI.
Schellinger PD; Jansen O; Fiebach JB; Heiland S; Steiner T; Schwab S; Pohlers O; Ryssel H; Sartor K; Hacke W
Stroke; 2000 Jun; 31(6):1318-28. PubMed ID: 10835451
[TBL] [Abstract][Full Text] [Related]
7. Assessing the Clinical Efficacy of Recombinant Tissue Plasminogen Activator on Acute Cerebral Infarction.
Wu T; Li P; Sun D
J Nanosci Nanotechnol; 2020 Dec; 20(12):7781-7786. PubMed ID: 32711658
[TBL] [Abstract][Full Text] [Related]
8. [Early intravenous thrombolysis with recombinant tissue plasminogen activator for acute cerebral infarction].
Wang SY; Wang XL; Zeng H; Zuo Y; Hu N; Li XY; Huang F; Yu HL; Wang HY
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Sep; 15(9):542-5. PubMed ID: 12971850
[TBL] [Abstract][Full Text] [Related]
9. Comparison of MRI-based thrombolysis for patients with middle cerebral artery occlusionLi YH; Li MH; Zhao ZG; Bai QK
Neurol India; 2009; 57(4):426-33. PubMed ID: 19770543
[TBL] [Abstract][Full Text] [Related]
10. Nonatrial Fibrillation was Associated With Early Neurological Improvement After Intravenous Thrombolysis With rt-PA in Patients With Acute Ischemic Stroke.
Liu J; Huang J; Xu H; Dai H
Neurologist; 2020 Mar; 25(2):28-32. PubMed ID: 32132497
[TBL] [Abstract][Full Text] [Related]
11. Exclusion of Isolated Cortical Swelling Can Increase Efficacy of Baseline Alberta Stroke Program Early CT Score in the Prediction of Prognosis in Acute Ischemic Stroke Patients Treated with Thrombolysis.
Naito T; Takeuchi S; Arai N
J Stroke Cerebrovasc Dis; 2015 Dec; 24(12):2754-8. PubMed ID: 26460245
[TBL] [Abstract][Full Text] [Related]
12. [Application of lean management in cost control of cerebral infarction single disease in stroke center].
Qin C; Pan L; Chen Q; Lin Q; Zhang D
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 May; 31(5):637-640. PubMed ID: 31198155
[TBL] [Abstract][Full Text] [Related]
13. Use of l-3-n-Butylphthalide within 24 h after intravenous thrombolysis for acute cerebral infarction.
Wang M; Feng Y; Yuan Y; Gui L; Wang J; Gao P; Qin B; Sima D; Wang Q; Pan W
Complement Ther Med; 2020 Aug; 52():102442. PubMed ID: 32951710
[TBL] [Abstract][Full Text] [Related]
14. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of intravenous thrombolysis with rt-PA and urokinase for patients with acute cerebral infarction.
Sun F; Liu H; Fu HX; Zhang S; Qian XD; Li JJ; Zhu YB; Zhang XX; Zhang J; Qiu HP; Kang LL; Hu YJ; Zhao L; Mi YJ; Gao YJ; Dou ZJ; Ma Z
J Int Med Res; 2020 May; 48(5):300060519895352. PubMed ID: 32357116
[TBL] [Abstract][Full Text] [Related]
16. Comparative study on the efficacy and safety of alteplase and urokinase in the treatment of acute cerebral infarction.
Bao H; Gao HR; Pan ML; Zhao L; Sun HB
Technol Health Care; 2021; 29(1):85-90. PubMed ID: 32925123
[TBL] [Abstract][Full Text] [Related]
17. Clinical effect of mechanical fragmentation combined with recombinant tissue plasminogen activator artery thrombolysis on acute cerebral infarction.
Jia XF; Hong Z; Fan JH; Zhang YM
J Biol Regul Homeost Agents; 2016; 30(3):821-826. PubMed ID: 27655505
[TBL] [Abstract][Full Text] [Related]
18. CLOTBUST: design of a randomized trial of ultrasound-enhanced thrombolysis for acute ischemic stroke.
Alexandrov AV; Wojner AW; Grotta JC;
J Neuroimaging; 2004 Apr; 14(2):108-12. PubMed ID: 15095554
[TBL] [Abstract][Full Text] [Related]
19. [Effect of modified Buyang Huanwu Decoction on hemorrhagic transformation after rt-PA intravenous thrombolysis in patients with super early cerebral infarction].
Lu YK; Yang HY; Liu XZ; Wang YH; Yang JH
Zhongguo Zhong Yao Za Zhi; 2019 Apr; 44(8):1696-1703. PubMed ID: 31090337
[TBL] [Abstract][Full Text] [Related]
20. Risk Factors for Hemorrhagic Transformation After Intravenous Thrombolysis in Acute Cerebral Infarction: A Retrospective Single-Center Study.
Xu X; Li C; Wan T; Gu X; Zhu W; Hao J; Bao H; Zuo L; Hu H; Li G
World Neurosurg; 2017 May; 101():155-160. PubMed ID: 28185970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]